Skip to main content
. 2021 Sep 15;18(5):315–328. doi: 10.1007/s11897-021-00529-8

Fig. 1.

Fig. 1

Possible mechanisms of SGLT2 inhibitors (SGLT2i) on the heart with respect to rather systemic (left panel), combined (middle panel) or myocardial effects (right panel). Image heart:

© Shutterstock/Vasif Maharov; Image human: © Shutterstock/10topvector